Amelanotic melanoma: Clinical presentation, diagnosis, and management.

Christina Jiang, Neelesh P Jain, Campbell L Stewart

Journal: Clinics in dermatology 2025;43(1):10-15

PMID: 39900311

Abstract

Amelanotic melanoma (AM) is a subtype of cutaneous melanoma with little or no pigment on visual or histopathologic examination and accounts for approximately 2% of melanoma cases. This uncommon variant is often misdiagnosed or diagnosed in late stages due to its variable clinical presentation and lack of established criteria for clinical diagnosis. AM often presents nonspecifically as a pink to red macule, papule, or dermal nodule; therefore, dermatoscopy and reflectance confocal microscopy are extremely helpful tools in the diagnosis of AM. Histopathologically, there is an attenuation or complete absence of melanin granules, and immunohistochemistry for melanocytic markers, such as S100, Melan-A, and HMB-45, may be necessary for accurate diagnosis. Like other types of melanomas, the Breslow depth, presence or absence of ulceration, and mitotic rate are necessary for diagnosis, staging, and management. The standard of treatment for AM includes surgical excision with margins based on staging with sentinel lymph node biopsy, if indicated. We present the clinical and histopathologic features, special techniques, differential diagnosis, and current management of AM.

Copyright © 2025. Published by Elsevier Inc.

Address: University of Connecticut School of Medicine, Farmington, Connecticut, USA.; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut, USA.; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut, USA; Dermatopathology Laboratory, University of Connecticut School of Medicine, Farmington, Connecticut, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.